Neko Health has raised a $260 million Series B from Lightspeed Venture Partners, Atomico, General Catalyst, OG Venture, Lakestar and Rosello (Martin Lorentzon). Covered in TechCrunch, Dagens Industri, Bloomberg, Financial Times (among others).
The money will be used for European and US expansion as well as R&D.
Neko Health says it has conducted 10,000 scans (with 80 % of members signing up for another scan after one year) and has more than 100,000 people on the waitlist in Stockholm and London for its health scan.
I think it is good for Stockholm with a mega round in a still reasonably early startup (even if Neko Health was founded in 2018). It has been a while since the last one (especially if excluding Vargas-related startups). Now the team at Neko Health, including many friends, ‘only’ have to continue to build a great product and execute expansion plans.
